Effect of rosiglitazone on fibrinolytic system in patients with coronary atherosclerotic heart disease combined with diabetes mellitus: Feasibility to prevent restenosis after stenting

Zhou YF; Yang XJ; Li HX; Lu Y; Jiang WP

doi:10.3321/j.issn:1673-8225.2007.34.006

Home>Articles>Effect of rosiglitazone on fibrinolytic system in patients with coronary atherosclerotic heart disease combined with diabetes mellitus: Feasibility to prevent restenosis after stenting

DOI: 10.3321/j.issn:1673-8225.2007.34.006

Effect of rosiglitazone on fibrinolytic system in patients with coronary atherosclerotic heart disease combined with diabetes mellitus: Feasibility to prevent restenosis after stenting

Zhou YF

Yang XJ

Li HX

Lu Y

Jiang WP

Machine-generated Keywords：

Publication Date：2007-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 6741-6744 )

Chinese Journal of Tissue Engineering Research

PKUISTIC

ISSN：1673-8225

Year, Vol.(Issue)：2007,11(34)